Leonid Timashev

Stock Analyst at RBC Capital

(0)
# 4556
Out of 5,358 analysts
80
Total ratings
30.99%
Success rate
-13.25%
Average return
15 Stocks
Name Action PT Current % Upside Ratings Updated
EWTX Edgewise Therapeutic...
Reiterates: Outperform
48 48
15.24 214.96% 12 Jun 5, 2025
CATX Perspective Therapeu...
Maintains: Outperform
15 16
3.33 380.48% 1 Jun 3, 2025
BHVN Biohaven
Downgrades: Sector Perform
54 21
17.01 23.46% 12 May 19, 2025
CYTK Cytokinetics
Maintains: Outperform
82 80
32.32 147.52% 3 May 7, 2025
ALKS Alkermes
Maintains: Sector Perform
39 40
31.72 26.1% 2 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
190 193
111.92 72.44% 9 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
1.35 492.59% 6 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
100 100
73.62 35.83% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.66 80.72% 1 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
40 40
20.14 98.61% 6 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sector Perform
70 70
68.77 1.79% 1 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
18 18
4.79 275.78% 4 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
86 86
34.97 145.93% 12 Dec 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sector Perform
4 4
3.99 0.25% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
240 20
n/a n/a 1 Oct 18, 2022